Clinical trials
Phase 1 Myelodysplastic Syndromes trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2016 | 2 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Hemavant Sciences GmbH | 1 |
| Janssen Research & Development, LLC | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Myeloproliferative Disorders | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms, Castration-Resistant | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.